Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+8.53%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$94B
AUM Growth
+$5.35B
(+6%)
Cap. Flow
-$11.1B
Cap. Flow
% of AUM
-11.77%
Top 10 Holdings %
Top 10 Hldgs %
22.25%
Holding
2,575
New
400
Increased
743
Reduced
692
Closed
262
Top Buys
| 1 |
Pinnacle West Capital
PNW
|
+$478M |
| 2 |
PNC Financial Services
PNC
|
+$302M |
| 3 |
Otis Worldwide
OTIS
|
+$243M |
| 4 |
Colgate-Palmolive
CL
|
+$232M |
| 5 |
NorthWestern Energy
NWE
|
+$194M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
+$525M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$295M |
| 3 |
CSX Corp
CSX
|
+$224M |
| 4 |
Dollar Tree
DLTR
|
+$185M |
| 5 |
Baxter International
BAX
|
+$182M |
Sector Composition
| 1 | Technology | 20.36% |
| 2 | Healthcare | 14.2% |
| 3 | Financials | 13.28% |
| 4 | Industrials | 9.5% |
| 5 | Consumer Discretionary | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Century Communities
CCS
$2.06B
| $75K | ﹤0.01% |
918
+122
| +15% | +$9.97K |
|
1352
Global Ship Lease
GSL
$1.14B
| $75K | ﹤0.01% |
3,295
+2,524
| +327% | +$57.5K |
|
1353
Thor Industries
THO
$5.83B
| $75K | ﹤0.01% |
728
+270
| +59% | +$27.8K |
|
|
GBT
1354
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $75K | ﹤0.01% |
2,579
+617
| +31% | +$17.9K |
|
|
AGEN
1355
Agenus
AGEN
$151M
| $74K | ﹤0.01% |
1,179
-2,019
| -63% | -$127K |
|
1356
Concrete Pumping Holdings
BBCP
$368M
| $74K | ﹤0.01% |
9,054
| – | – |
|
1357
Globus Medical
GMED
$8.05B
| $74K | ﹤0.01% |
1,030
-11,853
| -92% | -$852K |
|
1358
Heidrick & Struggles
HSII
$1.05B
| $74K | ﹤0.01% |
1,697
+121
| +8% | +$5.28K |
|
1359
Regal Rexnord
RRX
$9.62B
| $74K | ﹤0.01% |
438
+142
| +48% | +$24K |
|
|
RWT
1360
Redwood Trust
RWT
$802M
| $74K | ﹤0.01% |
5,673
+5,184
| +1,060% | +$67.6K |
|
1361
Apyx Medical
APYX
$75.6M
| $73K | ﹤0.01% |
5,770
+478
| +9% | +$6.05K |
|
1362
Cracker Barrel
CBRL
$1.16B
| $73K | ﹤0.01% |
572
+293
| +105% | +$37.4K |
|
1363
CNB Financial Corp
CCNE
$768M
| $73K | ﹤0.01% |
2,776
+1,046
| +60% | +$27.5K |
|
1364
Franklin Covey
FC
$246M
| $73K | ﹤0.01% |
1,590
-306
| -16% | -$14K |
|
1365
FibroGen
FGEN
$50.3M
| $73K | ﹤0.01% |
207
-1,675
| -89% | -$591K |
|
1366
iShares Global 100 ETF
IOO
$7.17B
| $73K | ﹤0.01% |
+939
| New | +$73K |
|
1367
Lifecore Biomedical
LFCR
$291M
| $73K | ﹤0.01% |
+6,655
| New | +$73K |
|
1368
QuinStreet
QNST
$939M
| $73K | ﹤0.01% |
4,014
+1,978
| +97% | +$36K |
|
1369
Vericel Corp
VCEL
$1.69B
| $73K | ﹤0.01% |
1,869
+216
| +13% | +$8.44K |
|
1370
Acadia Pharmaceuticals
ACAD
$4.08B
| $72K | ﹤0.01% |
3,115
+506
| +19% | +$11.7K |
|
1371
Brink's
BCO
$4.9B
| $72K | ﹤0.01% |
+1,107
| New | +$72K |
|
1372
Douglas Emmett
DEI
$2.81B
| $72K | ﹤0.01% |
+2,158
| New | +$72K |
|
1373
Farmers National Banc Corp
FMNB
$570M
| $72K | ﹤0.01% |
3,895
+420
| +12% | +$7.76K |
|
1374
Generac Holdings
GNRC
$11B
| $72K | ﹤0.01% |
206
-47,723
| -100% | -$16.7M |
|
1375
Onto Innovation
ONTO
$5.3B
| $72K | ﹤0.01% |
+716
| New | +$72K |
|